Vault-13

Rock Springs Capital Management LP

Baltimore, MD · CIK 1595725 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2013 · limited partnership

$2.0bn reported value +20.8% vs Q1 2026
104positions
44.0%in top 10
17 new 40 added 30 reduced 13 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 1,105,210 $207.0m10.10% 10.10% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 1.1m -104.3k -104,255 -8.6%
2 TRAVERE THERAPEUTICS INC COM TVTX TVTX 2,179,069 $123.8m6.04% 6.04% AddedShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 1.5m, Q2 2026 2.2m +701.1k +701,115 47.4%
3 ELI LILLY & CO COM LLY LLY 98,700 $118.4m5.78% 5.78% UnchangedShares held: Q3 2025 105.4k, Q4 2025 105.4k, Q1 2026 98.7k, Q2 2026 98.7k
4 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 174,999 $94.0m4.59% 4.59% AddedShares held: Q3 2025 137.7k, Q4 2025 139.6k, Q1 2026 171.0k, Q2 2026 175.0k +4.0k +4,000 2.3%
5 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 798,145 $93.4m4.56% 4.56% ReducedShares held: Q3 2025 761.1k, Q4 2025 762.3k, Q1 2026 811.3k, Q2 2026 798.1k -13.1k -13,149 -1.6%
6 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 692,598 $76.9m3.75% 3.75% AddedShares held: Q3 2025 717.1k, Q4 2025 695.0k, Q1 2026 689.7k, Q2 2026 692.6k +2.9k +2,850 0.4%
7 KYMERA THERAPEUTICS INC COM KYMR KYMR 453,156 $52.0m2.54% 2.54% ReducedShares held: Q3 2025 450.4k, Q4 2025 496.9k, Q1 2026 496.9k, Q2 2026 453.2k -43.7k -43,715 -8.8%
8 ARGENX SE SPONSORED ADR ARGX ARGX 52,750 $48.9m2.39% 2.39% ReducedShares held: Q3 2025 142.8k, Q4 2025 103.2k, Q1 2026 98.5k, Q2 2026 52.8k -45.8k -45,750 -46.5%
9 ASCENDIS PHARMA A/S ORD SHS ASND ASND 168,750 $45.0m2.20% 2.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 168.8k
10 XENON PHARMACEUTICALS INC COM XENE XENE 683,907 $41.3m2.01% 2.01% ReducedShares held: Q3 2025 851.7k, Q4 2025 787.8k, Q1 2026 763.0k, Q2 2026 683.9k -79.1k -79,113 -10.4%
11 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 715,452 $39.3m1.92% 1.92% ReducedShares held: Q3 2025 794.1k, Q4 2025 733.5k, Q1 2026 739.8k, Q2 2026 715.5k -24.4k -24,364 -3.3%
12 INSMED INC COM PAR $.01 INSM INSM 362,150 $38.6m1.88% 1.88% AddedShares held: Q3 2025 385.0k, Q4 2025 319.2k, Q1 2026 314.3k, Q2 2026 362.1k +47.9k +47,850 15.2%
13 PENUMBRA INC COM PEN PEN 115,750 $36.5m1.78% 1.78% ReducedShares held: Q3 2025 120.5k, Q4 2025 120.5k, Q1 2026 120.5k, Q2 2026 115.8k -4.8k -4,750 -3.9%
14 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 640,317 $34.4m1.68% 1.68% AddedShares held: Q3 2025 951.2k, Q4 2025 748.2k, Q1 2026 640.2k, Q2 2026 640.3k +100 +100 0.0%
15 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 967,855 $32.3m1.58% 1.58% ReducedShares held: Q3 2025 1.2m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 967.9k -250.9k -250,918 -20.6%
16 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 269,650 $32.1m1.57% 1.57% AddedShares held: Q3 2025 235.0k, Q4 2025 235.0k, Q1 2026 261.8k, Q2 2026 269.6k +7.9k +7,900 3.0%
17 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 76,460 $30.4m1.48% 1.48% ReducedShares held: Q3 2025 82.0k, Q4 2025 82.0k, Q1 2026 82.0k, Q2 2026 76.5k -5.5k -5,540 -6.8%
18 AGILON HEALTH INC COM NEW AGL AGL 262,600 $28.1m1.37% 1.37% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 260.0k, Q2 2026 262.6k +2.6k +2,600 1.0%
19 UNITEDHEALTH GROUP INC COM UNH UNH 63,750 $26.5m1.29% 1.29% AddedShares held: Q3 2025 0, Q4 2025 40.8k, Q1 2026 53.0k, Q2 2026 63.8k +10.8k +10,750 20.3%
20 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 699,146 $26.0m1.27% 1.27% AddedShares held: Q3 2025 721.5k, Q4 2025 692.5k, Q1 2026 650.3k, Q2 2026 699.1k +48.9k +48,876 7.5%
21 ERASCA INC COM ERAS ERAS 1,402,150 $25.7m1.25% 1.25% AddedShares held: Q3 2025 0, Q4 2025 951.7k, Q1 2026 1.1m, Q2 2026 1.4m +298.7k +298,681 27.1%
22 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 144,750 $24.4m1.19% 1.19% ReducedShares held: Q3 2025 89.8k, Q4 2025 125.5k, Q1 2026 150.4k, Q2 2026 144.8k -5.7k -5,700 -3.8%
23 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 464,625 $23.6m1.15% 1.15% ReducedShares held: Q3 2025 686.1k, Q4 2025 798.4k, Q1 2026 826.5k, Q2 2026 464.6k -361.9k -361,875 -43.8%
24 TENET HEALTHCARE CORP COM NEW THC THC 125,000 $23.4m1.14% 1.14% UnchangedShares held: Q3 2025 125.0k, Q4 2025 125.0k, Q1 2026 125.0k, Q2 2026 125.0k
25 DEXCOM INC COM DXCM DXCM 343,000 $23.1m1.13% 1.13% ReducedShares held: Q3 2025 316.9k, Q4 2025 347.3k, Q1 2026 355.6k, Q2 2026 343.0k -12.6k -12,600 -3.5%
26 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,330,532 $22.9m1.12% 1.12% ReducedShares held: Q3 2025 4.6m, Q4 2025 4.5m, Q1 2026 4.5m, Q2 2026 4.3m -142.1k -142,118 -3.2%
27 MINIMED GROUP INC COM MMED MMED 1,520,000 $22.7m1.11% 1.11% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.5m +465.0k +465,000 44.1%
28 BOSTON SCIENTIFIC CORP COM BSX BSX 528,500 $22.6m1.10% 1.10% AddedShares held: Q3 2025 360.2k, Q4 2025 399.1k, Q1 2026 515.3k, Q2 2026 528.5k +13.2k +13,200 2.6%
29 PHARVARIS N V COM PHVS PHVS 648,333 $22.4m1.09% 1.09% AddedShares held: Q3 2025 623.4k, Q4 2025 623.4k, Q1 2026 645.5k, Q2 2026 648.3k +2.8k +2,800 0.4%
30 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 662,918 $21.8m1.07% 1.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 662.9k
31 HEMAB THERAPEUTICS HLDGS INC COM SHS COAG COAG 575,432 $21.1m1.03% 1.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 575.4k
32 DYNE THERAPEUTICS INC COM DYN DYN 942,154 $20.9m1.02% 1.02% ReducedShares held: Q3 2025 824.1k, Q4 2025 913.0k, Q1 2026 972.2k, Q2 2026 942.2k -30.0k -30,044 -3.1%
33 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 66,750 $20.1m0.98% 0.98% ReducedShares held: Q3 2025 74.2k, Q4 2025 71.2k, Q1 2026 74.0k, Q2 2026 66.8k -7.2k -7,250 -9.8%
34 COGENT BIOSCIENCES INC COM COGT COGT 515,917 $20.0m0.97% 0.97% ReducedShares held: Q3 2025 1.0m, Q4 2025 849.0k, Q1 2026 624.2k, Q2 2026 515.9k -108.2k -108,238 -17.3%
35 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 532,563 $19.8m0.96% 0.96% ReducedShares held: Q3 2025 958.5k, Q4 2025 799.2k, Q1 2026 799.2k, Q2 2026 532.6k -266.6k -266,600 -33.4%
36 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 582,744 $19.7m0.96% 0.96% ReducedShares held: Q3 2025 595.9k, Q4 2025 557.2k, Q1 2026 588.8k, Q2 2026 582.7k -6.0k -6,050 -1.0%
37 VERA THERAPEUTICS INC CL A VERA VERA 427,584 $18.3m0.90% 0.90% ReducedShares held: Q3 2025 617.4k, Q4 2025 568.6k, Q1 2026 503.6k, Q2 2026 427.6k -76.0k -76,001 -15.1%
38 TARSUS PHARMACEUTICALS INC COM TARS TARS 277,087 $17.4m0.85% 0.85% AddedShares held: Q3 2025 288.3k, Q4 2025 260.3k, Q1 2026 225.2k, Q2 2026 277.1k +51.9k +51,908 23.1%
39 HEARTFLOW INC COM HTFL HTFL 573,500 $16.8m0.82% 0.82% AddedShares held: Q3 2025 250.0k, Q4 2025 277.7k, Q1 2026 572.5k, Q2 2026 573.5k +1.0k +1,000 0.2%
40 MBX BIOSCIENCES INC COM MBX MBX 298,218 $16.5m0.80% 0.80% AddedShares held: Q3 2025 282.6k, Q4 2025 282.6k, Q1 2026 288.0k, Q2 2026 298.2k +10.3k +10,251 3.6%
41 CYTOKINETICS INC COM NEW CYTK CYTK 187,980 $16.0m0.78% 0.78% AddedShares held: Q3 2025 0, Q4 2025 35.9k, Q1 2026 45.4k, Q2 2026 188.0k +142.6k +142,616 314.4%
42 BICARA THERAPEUTICS INC COM BCAX BCAX 535,286 $15.9m0.78% 0.78% AddedShares held: Q3 2025 370.7k, Q4 2025 429.1k, Q1 2026 489.1k, Q2 2026 535.3k +46.2k +46,191 9.4%
43 PARABILIS MEDICINES INC COM PBLS PBLS 578,028 $15.8m0.77% 0.77% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 578.0k
44 ZAI LAB LTD ADR ZLAB ZLAB 814,707 $15.5m0.76% 0.76% UnchangedShares held: Q3 2025 791.2k, Q4 2025 811.5k, Q1 2026 814.7k, Q2 2026 814.7k
45 DANAHER CORPORATION COM DHR DHR 76,300 $14.5m0.71% 0.71% AddedShares held: Q3 2025 61.5k, Q4 2025 61.5k, Q1 2026 61.5k, Q2 2026 76.3k +14.8k +14,800 24.1%
46 TANGO THERAPEUTICS INC COM TNGX TNGX 456,551 $14.3m0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 386.9k, Q1 2026 386.9k, Q2 2026 456.6k +69.6k +69,636 18.0%
47 EVOLENT HEALTH INC CL A EVH EVH 2,500,000 $13.6m0.66% 0.66% ReducedShares held: Q3 2025 3.0m, Q4 2025 2.7m, Q1 2026 2.7m, Q2 2026 2.5m -175.0k -175,000 -6.5%
48 PTC THERAPEUTICS INC COM PTCT PTCT 162,298 $13.2m0.65% 0.65% AddedShares held: Q3 2025 0, Q4 2025 61.9k, Q1 2026 161.8k, Q2 2026 162.3k +500 +500 0.3%
49 MINERALYS THERAPEUTICS INC COM MLYS MLYS 484,951 $13.1m0.64% 0.64% AddedShares held: Q3 2025 408.3k, Q4 2025 427.6k, Q1 2026 439.8k, Q2 2026 485.0k +45.2k +45,200 10.3%
50 ZENAS BIOPHARMA INC COM ZBIO ZBIO 502,077 $12.7m0.62% 0.62% UnchangedShares held: Q3 2025 580.7k, Q4 2025 502.1k, Q1 2026 502.1k, Q2 2026 502.1k
51 ARDELYX INC COM ARDX ARDX 2,241,769 $11.4m0.56% 0.56% ReducedShares held: Q3 2025 2.3m, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.2m -57.7k -57,704 -2.5%
52 INSPIRE MED SYS INC COM INSP INSP 244,000 $10.9m0.53% 0.53% AddedShares held: Q3 2025 110.5k, Q4 2025 131.0k, Q1 2026 131.8k, Q2 2026 244.0k +112.2k +112,200 85.1%
53 BRIDGEBIO PHARMA INC COM BBIO BBIO 144,750 $10.8m0.53% 0.53% AddedShares held: Q3 2025 85.0k, Q4 2025 103.5k, Q1 2026 128.2k, Q2 2026 144.8k +16.5k +16,500 12.9%
54 ALKERMES PLC SHS ALKS ALKS 199,811 $10.5m0.51% 0.51% AddedShares held: Q3 2025 106.5k, Q4 2025 139.2k, Q1 2026 184.0k, Q2 2026 199.8k +15.8k +15,825 8.6%
55 SUMMIT THERAPEUTICS INC COM SMMT SMMT 715,000 $10.4m0.51% 0.51% AddedShares held: Q3 2025 710.0k, Q4 2025 710.0k, Q1 2026 710.0k, Q2 2026 715.0k +5.0k +5,000 0.7%
56 AZENTA INC COM AZTA AZTA 403,000 $10.3m0.50% 0.50% ReducedShares held: Q3 2025 540.4k, Q4 2025 569.1k, Q1 2026 569.1k, Q2 2026 403.0k -166.1k -166,100 -29.2%
57 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 245,500 $10.1m0.49% 0.49% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 245.5k +45.5k +45,500 22.8%
58 STRYKER CORPORATION COM SYK SYK 29,000 $9.1m0.45% 0.45% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.8k, Q2 2026 29.0k +14.2k +14,200 96.0%
59 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 499,764 $9.0m0.44% 0.44% UnchangedShares held: Q3 2025 499.8k, Q4 2025 499.8k, Q1 2026 499.8k, Q2 2026 499.8k
60 CARIS LIFE SCIENCES INC COM CAI CAI 487,500 $8.7m0.42% 0.42% ReducedShares held: Q3 2025 793.7k, Q4 2025 687.5k, Q1 2026 563.0k, Q2 2026 487.5k -75.5k -75,500 -13.4%
61 OMADA HEALTH INC COM OMDA OMDA 373,000 $8.2m0.40% 0.40% ReducedShares held: Q3 2025 920.0k, Q4 2025 740.0k, Q1 2026 541.0k, Q2 2026 373.0k -168.0k -168,000 -31.1%
62 COMPASS THERAPEUTICS INC COM CMPX CMPX 3,524,929 $7.7m0.38% 0.38% AddedShares held: Q3 2025 4.5m, Q4 2025 3.9m, Q1 2026 3.3m, Q2 2026 3.5m +219.6k +219,621 6.6%
63 IMMUNOME INC COM IMNM IMNM 347,666 $7.4m0.36% 0.36% UnchangedShares held: Q3 2025 0, Q4 2025 347.7k, Q1 2026 347.7k, Q2 2026 347.7k
64 EDAP TMS S A SPONSORED ADR FOCL FOCL 1,386,000 $7.2m0.35% 0.35% AddedShares held: Q3 2025 1.3m, Q4 2025 1.3m, Q1 2026 1.4m, Q2 2026 1.4m +8.0k +8,000 0.6%
65 PHREESIA INC COM PHR PHR 696,900 $7.2m0.35% 0.35% AddedShares held: Q3 2025 749.1k, Q4 2025 876.6k, Q1 2026 600.4k, Q2 2026 696.9k +96.5k +96,500 16.1%
66 OMEROS CORP COM OMER OMER 718,499 $6.8m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 718.5k
67 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 143,187 $6.7m0.33% 0.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 143.2k
68 CORCEPT THERAPEUTICS INC COM CORT CORT 72,000 $6.3m0.31% 0.31% AddedShares held: Q3 2025 0, Q4 2025 50.2k, Q1 2026 50.2k, Q2 2026 72.0k +21.8k +21,750 43.3%
69 JANUX THERAPEUTICS INC COM JANX JANX 367,009 $5.6m0.28% 0.28% UnchangedShares held: Q3 2025 210.4k, Q4 2025 358.8k, Q1 2026 367.0k, Q2 2026 367.0k
70 MOBIA MED INC COMMON STOCK MOBI MOBI 418,200 $5.6m0.27% 0.27% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 418.2k
71 ARCUS BIOSCIENCES INC COM RCUS RCUS 180,000 $5.5m0.27% 0.27% UnchangedShares held: Q3 2025 0, Q4 2025 180.0k, Q1 2026 180.0k, Q2 2026 180.0k
72 THERMO FISHER SCIENTIFIC INC COM TMO TMO 10,000 $5.0m0.24% 0.24% UnchangedShares held: Q3 2025 10.0k, Q4 2025 10.0k, Q1 2026 10.0k, Q2 2026 10.0k
73 TREVI THERAPEUTICS INC COM TRVI TRVI 260,000 $4.8m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 260.0k
74 SIONNA THERAPEUTICS INC COM SION SION 99,429 $4.4m0.21% 0.21% UnchangedShares held: Q3 2025 99.4k, Q4 2025 99.4k, Q1 2026 99.4k, Q2 2026 99.4k
75 CVS HEALTH CORP COM CVS CVS 40,000 $4.1m0.20% 0.20% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.0k, Q2 2026 40.0k
76 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 268,519 $3.8m0.19% 0.19% AddedShares held: Q3 2025 31.7k, Q4 2025 258.7k, Q1 2026 258.7k, Q2 2026 268.5k +9.8k +9,780 3.8%
77 OCULAR THERAPEUTIX INC COM OCUL OCUL 383,716 $3.8m0.18% 0.18% UnchangedShares held: Q3 2025 300.0k, Q4 2025 345.8k, Q1 2026 383.7k, Q2 2026 383.7k
78 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 42,254 $3.8m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 42.3k
79 TALPHERA INC COM NEW TLPH TLPH 3,589,186 $3.7m0.18% 0.18% UnchangedShares held: Q3 2025 3.6m, Q4 2025 3.6m, Q1 2026 3.6m, Q2 2026 3.6m
80 ROIVANT SCIENCES LTD SHS ROIV ROIV 101,000 $3.6m0.17% 0.17% AddedShares held: Q3 2025 0, Q4 2025 88.8k, Q1 2026 97.0k, Q2 2026 101.0k +4.0k +4,000 4.1%
81 VAXCYTE INC COM PCVX PCVX 60,250 $3.5m0.17% 0.17% UnchangedShares held: Q3 2025 11.1k, Q4 2025 47.0k, Q1 2026 60.2k, Q2 2026 60.2k
82 NEUROGENE INC COM NGNE NGNE 106,750 $3.4m0.16% 0.16% AddedShares held: Q3 2025 104.3k, Q4 2025 104.3k, Q1 2026 104.3k, Q2 2026 106.8k +2.4k +2,411 2.3%
83 CENTURY THERAPEUTICS INC COM IPSC IPSC 1,304,347 $3.2m0.16% 0.16% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.3m
84 ALPHATEC HLDGS INC COM NEW ATEC ATEC 360,000 $3.1m0.15% 0.15% AddedShares held: Q3 2025 302.5k, Q4 2025 302.5k, Q1 2026 350.0k, Q2 2026 360.0k +10.0k +10,000 2.9%
85 NOVO-NORDISK A S ADR NVO NVO 63,500 $3.0m0.15% 0.15% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 90.0k, Q2 2026 63.5k -26.5k -26,500 -29.4%
86 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 235,178 $2.9m0.14% 0.14% AddedShares held: Q3 2025 0, Q4 2025 98.2k, Q1 2026 170.4k, Q2 2026 235.2k +64.8k +64,800 38.0%
87 NERVGEN PHARMA CORP COM NGEN NGEN 1,208,231 $2.5m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
88 MEDTRONIC PLC SHS MDT MDT 30,900 $2.4m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.9k
89 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 59,000 $2.0m0.10% 0.10% AddedShares held: Q3 2025 0, Q4 2025 45.5k, Q1 2026 45.5k, Q2 2026 59.0k +13.5k +13,500 29.7%
90 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 20,326 $2.0m0.10% 0.10% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 26.8k, Q2 2026 20.3k -6.4k -6,431 -24.0%
91 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 250,000 $1.9m0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
92 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 74,448 $1.8m0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 74.4k
93 LENZ THERAPEUTICS INC COM LENZ LENZ 257,460 $1.5m0.07% 0.07% UnchangedShares held: Q3 2025 236.2k, Q4 2025 257.5k, Q1 2026 257.5k, Q2 2026 257.5k
94 ALTIMMUNE INC COM NEW ALT ALT 471,465 $1.4m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 471.5k
95 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 65,000 $1.4m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 65.0k
96 SURGERY PARTNERS INC COM SGRY SGRY 84,000 $1.4m0.07% 0.07% ReducedShares held: Q3 2025 0, Q4 2025 310.0k, Q1 2026 208.0k, Q2 2026 84.0k -124.0k -124,000 -59.6%
97 AXSOME THERAPEUTICS INC COM AXSM AXSM 5,500 $1.3m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.5k
98 ORUKA THERAPEUTICS INC COM ORKA ORKA 12,051 $1.1m0.06% 0.06% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.1k, Q2 2026 12.1k +7.9k +7,928 192.3%
99 VIKING THERAPEUTICS INC COM VKTX VKTX 25,500 $994.8k0.05% 0.05% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 96.0k, Q2 2026 25.5k -70.5k -70,500 -73.4%
100 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 33,500 $967.5k0.05% 0.05% ReducedShares held: Q3 2025 0, Q4 2025 33.8k, Q1 2026 40.5k, Q2 2026 33.5k -7.0k -7,000 -17.3%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 194,000 $44.4m194.0k shares
ARCELLX INC ACLX ACLX 169,859 $19.5m169.9k shares
CENTESSA PHARMACEUTICALS PLC 351,828 $14.0m351.8k shares
SOLENO THERAPEUTICS INC SLNO SLNO 257,253 $8.6m257.3k shares
REGENERON PHARMACEUTICALS REGN REGN 10,100 $7.8m10.1k shares
APELLIS PHARMACEUTICALS INC APLS APLS 162,750 $6.5m162.8k shares
TERNS PHARMACEUTICALS INC 113,748 $6.0m113.7k shares
SPDR SER TR XBI XBI 30,000 $3.8m30.0k shares
EDWARDS LIFESCIENCES CORP EW EW 28,900 $2.3m28.9k shares
ACADIA HEALTHCARE COMPANY IN ACHC ACHC 75,500 $1.8m75.5k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 5,750 $1.1m5.8k shares
GOSSAMER BIO INC GOSS GOSS 1,609,492 $528.7k1.6m shares
AMICUS THERAPEUTICS INC FOLD FOLD 21,062 $304.6k21.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
TALPHERA INC TLPH · 13G · filed 2025-09-12 TLPH 7.9%≈ $3.7m new 13G 2025-09-12